Virios Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Dogwood Therapeutics

11/05/2023 21:32

* Virios Therapeutics Inc  VIRI.OQ  reported a quarterly
adjusted
loss of 8 cents​​ per share for the quarter ended in March. The
mean expectation of two analysts for the quarter was for a loss
of 20 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Virios Therapeutics Inc's reported EPS for the quarter was
a
loss of 8 cents​.
    * The mean earnings estimate of analysts had fallen by
about 25%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Virios Therapeutics Inc shares had risen by 212.9% this
quarter and gained 387.3% so far this year.
    * The company reported a quarterly loss of $1.52 million.
    * Wall Street's median 12-month price target for Virios
Therapeutics Inc is $2.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
11 at 08:32 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.20          -0.08          Beat
 Dec. 31 2022      -0.15          -0.11          Beat
 Sep. 30 2022      -0.49          -0.28          Beat
 Jun. 30 2022      -0.50          -0.44          Beat